CYCN Cyclerion Therapeutics, Inc. - Common Stock
$3,04
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 12, 2026
Zakres 52 tyg.
$1–$8
27% of range
Ocena Analityków
BUY
7 analysts
Cena Docelowa
$8
+164% upside
P/E (TTM)
-1.1
ROE
—
Marża Zysku Netto
—
CYCN Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$3.04
Kapitalizacja Rynkowa
—
P/E (TTM)
-1.1
EPS (TTM)
$-1.11
Przychody (TTM)
$2M
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$1 – $8
CYCN Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$2M
2019-12-31
→
2025-12-31
EPS
$-1.11
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
2019-12-31
→
2022-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CYCN
Mediana porównawcza
P/E (TTM)
-1.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CYCN
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CYCN
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CYCN
Mediana porównawcza
Revenue YoY (Przychody R/R)
3.7%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
91.1%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
-2.0%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CYCN
Mediana porównawcza
CYCN Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
7 analityków
- Mocne kupno 2 28,6%
- Kup 4 57,1%
- Trzymaj 1 14,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
1 analityków · 2026-05-18
Niski
$8.00
Wysoki
$8.00
Średni cel
$8.00
+163,6%
Średnia cel
$8.00
+163,6%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.37%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 grudnia 2025 | $-0.21 | $-0.39 | 0.18% |
| 30 września 2025 | $-0.30 | — | — |
| 30 czerwca 2025 | $-0.11 | — | — |
| 30 września 2023 | $-0.93 | $-0.34 | -0.59% |
| 30 września 2022 | $-4.80 | $-6.32 | 1.5% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CYCN | — | -1.1 | 3.7% | — | — | — |
| INAB | $23M | -0.5 | — | — | -90.8% | — |
| ERNA | — | — | — | — | — | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $0 | $297.0K | $4M | $2M | $5M | |
| R&D Expense | $959.0K | $286.0K | $2M | $6M | $38M | $56M | $95M | |
| SG&A Expense | $6M | $5M | $8M | $13M | $21M | $29M | $34M | |
| Operating Expenses | $7M | $6M | $13M | $19M | $59M | $84M | $130M | |
| Operating Income | $-5M | $-4M | $-13M | $-19M | $-55M | $-81M | $-125M | |
| Other Non-op | $1M | $571.0K | $358.0K | $294.0K | $-16.0K | $588.0K | · | |
| Pretax Income | $-4M | $-3M | $-5M | $-44M | $-52M | $-122M | $-122M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-4M | $-3M | $-5M | $-44M | $-52M | $-78M | $-123M | |
| EPS (Basic) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | · | · | |
| EPS (Diluted) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | · | · | |
| Shares (Basic) | 3,181,000 | 2,518,000 | 2,338,000 | 2,173,000 | 39,144,000 | · | · | |
| Shares (Diluted) | 3,181,000 | 2,518,000 | 2,338,000 | 2,173,000 | 39,144,000 | · | · | |
| EBITDA | · | $-4M | $-13M | $-44M | $-55M | · | $-125M |
Bilans 21
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $8M | $13M | $54M | $54M | $95M | |
| Receivables | $1M | $556.0K | $0 | $96.0K | $100.0K | $0 | · | |
| Prepaid Expense | $384.0K | $421.0K | $442.0K | $805.0K | $928.0K | $816.0K | $2M | |
| Other Current Assets | $11.0K | $16.0K | $11.0K | $537.0K | $468.0K | $3M | $3M | |
| Current Assets | $5M | $4M | $8M | $15M | $55M | $59M | $101M | |
| PP&E (Net) | $0 | $0 | $0 | $0 | $65.0K | $7M | $12M | |
| PP&E (Gross) | · | $126.0K | $126.0K | $2M | $2M | $17M | $33M | |
| Accum. Depreciation | · | $126.0K | $126.0K | $2M | $2M | $10M | $22M | |
| Other Non-current Assets | · | · | $0 | $2M | $2M | $3M | $540.0K | |
| Total Assets | $10M | $10M | $13M | $18M | $59M | $115M | $186M | |
| Accounts Payable | $508.0K | $390.0K | $1M | $3M | $2M | $1M | $3M | |
| Short-term Debt | · | · | · | $4M | $4M | $4M | · | |
| Current Liabilities | $900.0K | $725.0K | $2M | $8M | $11M | $17M | $18M | |
| Capital Leases | · | · | · | · | $0 | $39M | $70M | |
| Total Debt | · | · | · | $4M | $4M | · | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Retained Earnings | $-271M | $-267M | $-264M | $-259M | $-215M | $-163M | $-86M | |
| AOCI | · | $0 | $-12.0K | $-20.0K | $-23.0K | $-27.0K | $-20.0K | |
| Stockholders' Equity | $9M | $9M | $11M | $10M | $48M | $59M | $98M | |
| Liabilities + Equity | $10M | $10M | $13M | $18M | $59M | $115M | $186M | |
| Shares Outstanding | 3,821,236 | 2,545,922 | 2,474,159 | 2,175,936 | 2,170,509 | 34,047,300 | 27,598,133 |
Przepływy pieniężne 11
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $65.0K | $472.0K | $2M | $3M | |
| Stock-based Comp | $441.0K | $625.0K | $1M | $6M | $10M | $15M | $20M | |
| Restructuring | · | · | $-565.0K | $-1M | · | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-21M | $-41M | $-37M | $-72M | $-102M | |
| CapEx | · | · | · | $0 | $7.0K | $2M | $7M | |
| Investing Cash Flow | · | $0 | $10M | $0 | $1M | $18.0K | $-7M | |
| Stock Issued | $1M | $0 | $5M | $0 | · | · | · | |
| Net Stock Activity | · | $0 | $5M | · | · | · | · | |
| Financing Cash Flow | $3M | $0 | $5M | $29.0K | $31M | $28M | $212M | |
| Net Change in Cash | $8.0K | $-4M | $-6M | $-41M | $-4M | $-44M | $103M | |
| Free Cash Flow | · | · | · | $-41M | $-37M | · | $-109M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -181.4% | · | -2730.6% | -1400.2% | · | -2774.3% | |
| Net Margin | · | -152.8% | · | -2712.5% | -1310.2% | · | -2729.3% | |
| Pretax Margin | · | -152.8% | · | -2712.5% | -1310.2% | · | -2715.9% | |
| EBITDA Margin | · | -181.4% | · | -2730.6% | -1400.2% | · | -2774.3% | |
| ROA | · | · | -33.5% | -113.9% | -59.1% | · | -126.9% | |
| ROE | · | · | -43.6% | -326.8% | -98.7% | · | -113.4% | |
| ROIC | · | · | -114.7% | -318.0% | -106.7% | · | -127.9% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 3.8 | 1.9 | 5.0 | · | 5.5 | |
| Quick Ratio | · | · | 3.6 | 1.8 | 4.9 | · | 5.2 | |
| Debt / Equity | · | · | · | 0.3 | 0.1 | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | 0.0 | 16.6 | 78.8 | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.7% | · | · | -92.5% | 71.7% | · | · | |
| Revenue CAGR 3Y | 91.1% | -20.2% | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $0 | $297.0K | $4M | $2M | $5M | |
| Net Income TTM | $-4M | $-3M | $-5M | $-44M | $-52M | $-78M | $-123M | |
| Market Cap | · | · | $8M | $571M | $1.49B | · | $1.50B | |
| Enterprise Value | · | · | · | $561M | $1.44B | · | · | |
| P/E | -1.1 | -2.7 | -1.5 | -0.6 | -26.1 | · | · | |
| P/S | · | · | · | 1922.4 | 378.8 | · | 333.1 | |
| P/B | · | · | 0.7 | 54.6 | 31.0 | · | 15.4 | |
| P / Tangible Book | 0.5 | 0.9 | 0.7 | 54.6 | 31.0 | 35.0 | · | |
| P / Cash Flow | · | · | -0.4 | -14.1 | -40.9 | · | -14.7 | |
| P / FCF | · | · | · | -14.1 | -40.9 | · | -13.8 | |
| EV / EBITDA | · | · | · | -12.6 | -26.1 | · | · | |
| EV / FCF | · | · | · | -13.8 | -39.5 | · | · | |
| EV / Revenue | · | · | · | 1889.2 | 366.0 | · | · | |
| Earnings Yield | -87.4% | -37.6% | -67.2% | -154.6% | -3.8% | · | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | $875.0K | $93.0K | $81.0K | $2M | $194.0K | $0 | $0 | $0 | $0 | $0 | $0 | $-720.0K | $0 | $306.0K | |
| R&D Expense | $730.0K | $519.0K | $348.0K | $56.0K | $36.0K | $56.0K | $81.0K | $105.0K | $44.0K | $24.0K | $580.0K | $339.0K | $572.0K | $-15M | $1M | $10M | |
| SG&A Expense | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $4M | |
| Operating Expenses | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $6M | $2M | $3M | $-13M | $5M | $14M | |
| Operating Income | $-3M | $-838.0K | $-1M | $-2M | $-1M | $502.0K | $-1M | $-1M | $-2M | $-2M | $-6M | $-2M | $-3M | $12M | $-5M | $-13M | |
| Other Non-op | $32.0K | $39.0K | $30.0K | $1M | $28.0K | $28.0K | $405.0K | $62.0K | $76.0K | $101.0K | $107.0K | $62.0K | $88.0K | $132.0K | $111.0K | $45.0K | |
| Net Income | $-3M | $-799.0K | $-976.0K | $-324.0K | $-1M | $530.0K | $-723.0K | $-1M | $-2M | $-2M | $8M | $-4M | $-7M | $-7M | $-10M | $-13M | |
| EPS (Basic) | $-0.76 | $-0.14 | $-0.30 | $-0.11 | $-0.56 | $0.23 | $-0.29 | $-0.53 | $-0.62 | $-0.32 | $3.10 | $-1.83 | $-3.20 | $-8.99 | $-4.83 | $-6.16 | |
| EPS (Diluted) | $-0.76 | $-0.14 | $-0.30 | $-0.11 | $-0.56 | $0.23 | $-0.29 | $-0.53 | $-0.62 | $0.06 | $2.72 | $-1.83 | $-3.20 | $-8.99 | $-4.83 | $-6.16 | |
| Shares (Basic) | 4,205,000 | -5,671,000 | 3,225,000 | 3,071,000 | 2,556,000 | -5,012,000 | 2,526,000 | 2,510,000 | 2,494,000 | -4,555,000 | 2,435,000 | 2,282,000 | 2,176,000 | -2,217,425 | 2,174,000 | 2,173,000 | |
| Shares (Diluted) | 4,205,000 | -5,671,000 | 3,225,000 | 3,071,000 | 2,556,000 | -5,012,000 | 2,526,000 | 2,510,000 | 2,494,000 | -4,906,000 | 2,786,000 | 2,282,000 | 2,176,000 | -2,217,425 | 2,174,000 | 2,173,000 | |
| EBITDA | $-3M | · | $-1M | $-2M | $-1M | · | $-1M | $-1M | $-2M | · | $-6M | $-4M | $-7M | · | $-11M | $-13M |
Bilans 18
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $5M | $3M | $4M | $3M | $3M | $5M | $6M | $8M | $9M | $6M | $7M | $13M | $20M | $30M | |
| Receivables | $0 | $1M | $100.0K | $525.0K | $581.0K | $556.0K | $44.0K | · | · | $0 | $0 | $0 | $96.0K | $96.0K | $227.0K | $227.0K | |
| Prepaid Expense | $255.0K | $384.0K | $386.0K | $462.0K | $256.0K | $421.0K | $621.0K | $116.0K | $308.0K | $442.0K | $726.0K | $1M | $567.0K | $805.0K | $536.0K | $647.0K | |
| Other Current Assets | $11.0K | $11.0K | $11.0K | $27.0K | $21.0K | $16.0K | $11.0K | $11.0K | $10.0K | $11.0K | $30.0K | $428.0K | $503.0K | $537.0K | $488.0K | $482.0K | |
| Current Assets | $3M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | $6M | $8M | $10M | $7M | $8M | $15M | $22M | $32M | |
| PP&E (Net) | $66.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| PP&E (Gross) | · | · | $126.0K | $126.0K | $126.0K | · | $126.0K | $126.0K | $126.0K | $126.0K | $126.0K | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | · | · | $126.0K | $126.0K | $126.0K | · | $126.0K | $126.0K | $126.0K | $126.0K | $126.0K | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $9M | $10M | $10M | $9M | $10M | $10M | $9M | $10M | $11M | $13M | $15M | $10M | $11M | $18M | $25M | $35M | |
| Accounts Payable | $457.0K | $508.0K | $480.0K | $462.0K | $483.0K | $390.0K | $304.0K | $651.0K | $741.0K | $1M | $814.0K | $2M | $4M | $3M | $2M | $3M | |
| Current Liabilities | $2M | $900.0K | $877.0K | $800.0K | $1M | $725.0K | $700.0K | $1M | $1M | $2M | $2M | $5M | $8M | $8M | $9M | $10M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-274M | $-271M | $-270M | $-269M | $-269M | $-267M | $-268M | $-267M | $-266M | $-264M | $-263M | $-270M | $-266M | $-259M | $-252M | $-241M | |
| AOCI | · | · | · | · | · | · | $0 | $0 | $-16.0K | $-12.0K | $-18.0K | $-16.0K | $-19.0K | $-20.0K | $-28.0K | $-25.0K | |
| Stockholders' Equity | $7M | $9M | $10M | $9M | $9M | $9M | $8M | $9M | $10M | $11M | $13M | $5M | $4M | $10M | $17M | $25M | |
| Liabilities + Equity | $9M | $10M | $10M | $9M | $10M | $10M | $9M | $10M | $11M | $13M | $15M | $10M | $11M | $18M | $25M | $35M | |
| Shares Outstanding | 4,241,260 | 3,821,236 | 3,695,158 | 3,075,968 | 3,060,944 | 2,545,922 | 2,530,898 | 2,515,874 | 2,499,601 | 2,474,159 | 2,445,096 | 2,407,796 | 43,524,894 | 2,175,936 | 43,494,184 | 43,479,835 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $17.0K | |
| Stock-based Comp | $58.0K | $95.0K | $118.0K | $114.0K | $114.0K | $122.0K | $138.0K | $184.0K | $181.0K | $103.0K | $159.0K | $379.0K | $426.0K | $1M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $-692.0K | $-127.0K | $0 | · | · | · | |
| Operating Cash Flow | $-1M | $-2M | $-264.0K | $-503.0K | $-968.0K | $360.0K | $-2M | $-1M | $-2M | $-2M | $-7M | $-7M | $-6M | $-7M | $-10M | $-11M | |
| CapEx | $66.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $-66.0K | · | · | · | $0 | · | $0 | · | · | $0 | $10M | · | · | $0 | $0 | $0 | |
| Stock Issued | · | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | · | |
| Net Stock Activity | · | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $825.0K | $251.0K | $2M | $-130.0K | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $12.0K | $0 | $17.0K | |
| Net Change in Cash | $-417.0K | $-1M | $2M | $-633.0K | $407.0K | $360.0K | $-2M | $-1M | $-2M | $-2M | $3M | $-2M | $-6M | $-7M | $-10M | $-11M | |
| Free Cash Flow | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentowność 5
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -115.0% | -1797.9% | -1798.8% | · | -581.4% | · | · | · | · | · | · | · | · | -4389.9% | |
| Net Margin | · | · | -111.5% | -348.4% | -1764.2% | · | -372.7% | · | · | · | · | · | · | · | · | -4375.2% | |
| EBITDA Margin | · | · | -115.0% | -1797.9% | -1798.8% | · | -581.4% | · | · | · | · | · | · | · | · | -4389.9% | |
| ROA | -34.6% | · | -10.1% | -3.3% | -13.5% | · | -6.0% | -13.1% | -13.5% | · | 37.6% | -18.5% | -24.0% | · | -22.6% | -24.1% | |
| ROE | -40.8% | · | -11.0% | -3.7% | -15.3% | · | -6.9% | -19.0% | -22.3% | · | 51.5% | -27.4% | -34.0% | · | -28.8% | -29.6% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | · | 5.8 | 5.0 | 4.2 | · | 5.1 | 3.7 | 4.2 | · | 4.2 | 1.4 | 1.1 | · | 2.5 | 3.2 | |
| Quick Ratio | 1.6 | · | 5.3 | 4.4 | 4.0 | · | 4.2 | 3.6 | 4.0 | · | 3.9 | 1.1 | 1.0 | · | 2.4 | 3.1 |
Efektywność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | 0.0 | · | 12.2 | 0.4 | 0.2 | · | 8.8 | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 2.7 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | · | $1M | $368.0K | $275.0K | · | $194.0K | $0 | $0 | · | $0 | $306.0K | $1M | · | $1M | $4M | |
| Net Income TTM | $-6M | · | $-3M | $-4M | $-5M | · | $4M | $521.0K | $-5M | · | $-14M | $-35M | $-44M | · | $-48M | $-54M | |
| Market Cap | $7M | · | $8M | $9M | $8M | · | $7M | $6M | $8M | · | $8M | $10M | $378M | · | $748M | $477M | |
| P/E | -0.9 | · | -1.8 | -2.0 | -1.2 | · | 2.0 | -8.8 | -1.1 | · | -0.5 | -0.3 | -0.6 | · | -1.5 | -1.5 | |
| P/S | 6.3 | · | 6.8 | 24.3 | 27.8 | · | 33.8 | · | · | · | · | 32.4 | 371.5 | · | 548.1 | 109.4 | |
| P/B | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | 1.9 | 96.3 | · | 45.3 | 18.8 | |
| P / Tangible Book | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | 1.9 | 96.3 | · | 45.3 | 18.8 | |
| P / Cash Flow | -5.6 | · | · | · | -7.9 | · | · | · | -4.3 | · | · | · | -60.8 | · | · | · | |
| P / FCF | -5.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -111.6% | · | -54.8% | -51.2% | -80.0% | · | 49.4% | -11.3% | -91.6% | · | -208.8% | -388.8% | -166.9% | · | -67.2% | -65.3% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $2M | $2M | $0 | $297.0K | $4M |
| Marża Operacyjna % | — | -181.4% | — | -2730.6% | -1400.2% |
| Zysk netto | $-4M | $-3M | $-5M | $-44M | $-52M |
| Rozwodniony EPS | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | — | 0.3 | 0.1 |
| Wskaźnik bieżący | — | — | 3.8 | 1.9 | 5.0 |
| Wskaźnik Szybkości | — | — | 3.6 | 1.8 | 4.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | — | — | $-41M | $-37M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.